Asymmetry Capital Management L.P. acquired a new position in KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 46,910 shares of the specialty pharmaceutical company's stock, valued at approximately $891,000. Asymmetry Capital Management L.P. owned 0.26% of KalVista Pharmaceuticals as of its most recent filing with the Securities & Exchange Commission.
